The association between serum uric acid (SUA) and prehypertension was evaluated in a racially admixed sample of civil servants aged 35 to 74 years, enrolled (2008-2010) in the Brazilian Longitudinal Study of Health (ELSA-Brasil). Of the 15 105 patients who enrolled in the study, we analyzed 3412 after excluding those who reported previous cardiovascular diseases, diabetes, or hypertension; were heavy drinkers; or had a body mass index (BMI) ≥35 kg/m2. Among the men, logistic regression, adjusted for age, race, income, birth weight, salt intake, insulin resistance, BMI, and renal function revealed odds ratios (ORs) and 95% confidence intervals (CIs) of prehypertension from the bottom quartile (referent) to the top quartile of SUA levels as follows: 0.84 (95% CI, 0.61-1.38), 0.97 (0.71-1.34) and 1.44 (1.04-2.0; P for trend .01). Analyzing for 1-standard deviation of change in SUA, the ORs were 1.19 (1.06-1.32). This association persisted in the subgroup analysis consisting of patients who were white, overweight, with a high salt intake but with normal renal function, and without metabolic syndrome. No association was found among women. In conclusion, SUA levels were associated with prehypertension among men.
MahomedF. On chronic Bright’s disease, and its essential symptoms. Lancet1879;113(2899):399–401.
2.
MellenPBBleyerAJErlingerTP. Serum uric acid predicts incident hypertension in a biethnic cohort the atherosclerosis risk in communities study. Hypertension. 2006;48(6):1037–1042.
3.
SundströmJSullivanLD’AgostinoRBLevyDKannelWBVasanRS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45(1):28–33.
4.
PerlsteinTSGumieniakOWilliamsGH. Uric acid and the development of hypertension the normative aging study. Hypertension. 2006;48(6):1031–1036.
5.
FormanJPChoiHCurhanGC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol. 2007;18(1):287–292.
6.
DawsonJJeemonPHetheringtonL. Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension. 2013;62(1):105–111.
7.
SyamalaSLiJShankarA. Association between serum uric acid and prehypertension among US adults. J Hypertens. 2007;25(8):1583–1589.
8.
LiangJXueYZouCZhangTSongHQiL. Serum uric acid and prehypertension among Chinese adults. J Hypertens. 2009;27(9):1761–1765.
9.
BaoXWangQChenGWangQLiangRZhangS. Serum concentration of uric acid associated with prehypertension among Chinese population. Angiology. 2014;65(9):800–805.
10.
KawamotoRTabaraYKoharaKKusunokiTAbeMMikiT. Interaction between serum uric acid and triglycerides in relation to prehypertension in community-dwelling Japanese adults. Clin Exp Hypertens. 2014;36(1):64–69.
11.
FeigDIMaderoMJalalDISanchez-LozadaLGJohnsonRJ. Uric acid and the origins of hypertension. J Pediatr. 2013;162(5):896–902.
12.
OdaMSattaYTakenakaOTakahataN. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 2002;19(5):640–653.
13.
JohnsonRJSautinYYOliverWJ. Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?J Comp Physiol B. 2009;179(1):67–76.
14.
BarkerDJPOsmondC. Low birth-weight and hypertension. BMJ. 1988;297(6641):134–135.
15.
Vuorinen-MarkkolaHYki-JärvinenH. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab. 1994;78(1):25–29.
16.
KawamotoRKoharaKTabaraYAbeMKusunokiTMikiT. Insulin resistance and prevalence of prehypertension and hypertension among community-dwelling persons. J Atheroscler Thromb. 2010; 17(2):148–55.
17.
WilsonBJWatsonMSPrescottGJ. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326(7394):845.
18.
FeigDISoletskyBJohnsonRJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008;300(8):924–932.
19.
SongKWangYWangG. Does decreasing serum uric acid level prevent hypertension? - A nested RCT in cohort study: rationale, methods, and baseline characteristics of study cohort. BMC Public Health. 2013;13:1069.
20.
LotufoPA. Setting up the longitudinal study for adult health (ELSA-Brasil). Rev Saude Publica. 2013;47(suppl 2):3–9.
21.
SchmidtMIDuncanBBMillJG. Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol. 2015;44(1):68–75.
22.
FedeliLGVidigalPGLeiteCM. Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil. Rev Saude Publica. 2013;47(suppl 2):63–71.
23.
SantosISBittencourtMSOliveiraIR. Carotid intima-media thickness value distributions in The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis. 2014;237(1):227–235.
24.
CoreshJAstorBDMcQuillanG. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39(5):920–929.
25.
ZanoccoJANishidaSKPassosMT. Race adjustment for estimating glomerular filtration rate is not always necessary. Nephron Extra. 2012;2(1):293–302.
26.
MillJGSilvaABBaldoMPMolinaMCRodriguesSL. Correlation between sodium and potassium excretion in 24- and 12-h urine samples. Braz J Med Biol Res. 2012;45(9):799–805.
27.
HugginsCEO’ReillySBrinkmanM. Relationship of urinary sodium and sodium-to-potassium ratio to blood pressure in older adults in Australia. Med J Aust. 2011;195(3):128–132.
28.
CookNRObarzanekECutlerJA. Trials of Hypertension Prevention Collaborative Research Group. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med. 2009;169(1):32–40.
29.
The Third Report of the National Cholesterol Education Program (NECP). Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497.
ChoiYJYoonYLeeKY. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J. 2014;28(7):3197–3204.
32.
FeigDINakagawaTKarumanchiSA. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004;66(4):281–287.
33.
BakerJFKrishnanEChenLSchumacherHR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?Am J Med. 2005;118(8):816–826.
